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Abstract
Spontaneous activity is an essential attribute of neuronal networks and plays a critical role in their development and
maintenance. Upon blockade of activity with tetrodotoxin (TTX), neurons degenerate slowly and die in a manner resembling
neurodegenerative diseases-induced neuronal cell death. The molecular cascade leading to this type of slow cell death is
not entirely clear. Primary post-natal cortical neurons were exposed to TTX for up to two weeks, followed by molecular,
biochemical and immunefluorescence analysis. The expression of the neuronal marker, neuron specific enolase (NSE), was
down-regulated, as expected, but surprisingly, there was a concomitant and striking elevation in expression of tissue-type
plasminogen activator (tPA). Immunofluorescence analysis indicated that tPA was highly elevated inside affected neurons.
Transfection of an endogenous tPA inhibitor, plasminogen activator inhibitor-1 (PAI-1), protected the TTX-exposed neurons
from dying. These results indicate that tPA is a pivotal player in slowly progressing activity deprivation-induced
neurodegeneration.
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Introduction
Spontaneous ongoing network activity plays a critical role in
neuronal development and survival, and regulates neuronal
functionality in many neural systems [1–3]. It is manifested in
the form of synchronized action potential discharges by neurons
comprising a functional network, both in-vivo and in-vitro.
Suppression of spontaneous ongoing network activity in culture
using the voltage-gated sodium channel blocker TTX, can have
fatal consequences to the exposed network which die following a
prolonged period of activity deprivation [4–6]. This protracted cell
death is caused by a gradual activation of cell death cascade and is
accompanied by an increase in miniature excitatory post-synaptic
currents (mEPSC) [4], proposed recently to be mediated by glial
tumor necrosis factor (TNF) [7], another acknowledged regulator
of cell death. Neuronal death is a key determinant in neurode-
generative diseases, and as yet there is little understanding of the
molecular cascade leading to slow cell death, hence it is a major
focus of attention in recent years.
Neuronal activity is responsible for the induction of key
neuronal genes, known as activity-regulated genes (e.g. BDNF)
[8]. One of them is the serine protease tPA, the principle enzyme
responsible for converting plasminogen into its active form,
plasmin. tPA mediates extracellular matrix degradation (and is
therefore the only approved drug for acute ischemic stroke) [9]
and affects neuronal interactions, but is also implicated in
neuronal death cascades [10–13]. The aim of the present study
was to further explore the mechanistic aspects that govern activity
deprivation-induced neuronal cell death. We found that tPA is up-
regulated in the chronically silenced neurons at both the mRNA
and the protein levels, and that it regulates TTX induced
neurotoxicity. We therefore propose tPA as a crucial mediator of
the toxic effects exerted by neuronal activity deprivation.
Results
We have previously shown that chronic blockade of activity by
exposure to TTX results in a slow and progressive degeneration of
the silenced neurons [5,6]. This is expressed as a massive reduction
in neuron number, and in a parallel reduction in the mRNA
expression level of neuron specific enolase (NSE) (14D, Fig. 1A).
We have also demonstrated the irreversibility of the death process,
which starts after 4 days of exposure to TTX and proceeds even
after TTX removal (designated the ‘wash’ period), through which
NSE continues to decrease (Fig. 1A, n=5 independent experi-
ments, p=261029 - one way ANOVA, p=0.97 - Shapiro-Wilk
normality test). In order to gain additional mechanistic insights on
cell death, we utilized real-time PCR analysis to examine the
involvement of key genes in the process. One of the factors
associated with the death process is tumor necrosis factor (TNF),
which was indeed highly elevated during TTX treatment (8-fold,
Fig. 1B), supporting previous suggestions [7]. However, TNF did
not remain elevated upon TTX removal, indicating that it may
not be involved in the death process, which is triggered by but no
longer dependent on continuous TTX presence. In sharp contrast,
tPA, maintained its high expression level also when the cells were
dying after removal of TTX (4-fold and 5-fold, respectively,
Fig. 1C, n=5 independent experiments, p,0.05 - one way
ANOVA, p=0.52 - Shapiro-Wilk normality test), indicating that it
may be involved in neuronal death caused by activity deprivation
(Fig. 1A). This elevation was detected in tPA protein levels as well,
as demonstrated by immunefluorescence staining (Fig. 1D),
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e25919correlating neuronal population loss with the induction of tPA
expression in individual neurons, and its concentration inside the
nucleus of the dying TTX-treated or -washed cell, in contrast to its
somatic localization in control neurons.
To determine if indeed tPA operates through an intracellular
route rather than the more prevalent extracellular arena, we tested
for the presence of secreted toxic factors in both TTX-conditioned
medium and in the medium conditioned by cells from which TTX
was removed (‘wash conditioning’). Naı ¨ve cells were exposed to
either fresh TTX, TTX-conditioned or wash-conditioned medi-
um, and cell survival rates and tPA mRNA expression level were
assessed (Fig. 2). While TTX-conditioned medium was as potent
as medium containing fresh TTX in inducing neuronal cell death
(Fig. 2A), wash-conditioned medium had no effect on cell viability
unless TTX was added, in which case it induced death in 60% of
the neurons (Fig. 2B, n=3 independent experiments, p,0.03 - t-
test, p=0.83 - Shapiro-Wilk normality test). Under these
conditions, tPA’s mRNA level was elevated by roughly 6 fold in
cells exposed to TTX-conditioned but not wash-conditioned
medium (Fig. 2A, n=3 independent experiments, p,0.04 - t-test,
p=0.83 - Shapiro-Wilk normality test).
If indeed tPA has a critical role in the process of neuronal cell
death, then interfering with its action should reduce it. Neurons
were transfected with the endogenous inhibitor of tPA, PAI-1 (a
gift of Rene Bernards, The Netherlands), which resulted in an
elevation in cell survival rates compared to cells transfected with
GFP or non-transfected cells (Fig. 3A&C).This protective effect,
observed in other model systems as well [14], was due to the
induced over-expression of PAI-1 as TTX by itself did not cause
any elevation in endogenous PAI-1 protein levels (as might be
assumed to be the case if any internal survival pathway was
activated, Fig. 3B), and indeed the enrichment in PAI-1-expressing
neurons was due to the transfection as appeared in the
immunefluorescence analysis (Fig. 3A).
Figure 1. NSE is down-regulated and tPA is up-regulated
during and following TTX application. (a–c) Real-time PCR analysis
showing the change in the mean mRNA expression level of the
neuronal marker NSE, TNF and tPA after short (4D) and long (14D) term
TTX treatment and following 4 days of TTX treatment after which it was
washed out and the cells were left to grow in regular medium for 10
more days (wash condition), relative to control (means6SEM;
*=P,0.05; ***=P,0.001). (d) Immunoflorescence images of control,
long term TTX-treated and TTX-washed cultures, stained for the
neuronal marker NeuN (green - left panel, bar=50 mm) or double-
labeled for NeuN and for tPA (red - right panel, bar=20 mm), showing
the elevation in tPA protein levels among the treated neurons and its
cellular localization.
doi:10.1371/journal.pone.0025919.g001
Figure 2. The effect of TTX and conditioned medium on the cell
survival and tPA expression level in neuronal cultures. (a) Mean
cell survival rates of primary neuronal cultures following the application
of 3 days TTX-conditioned medium or fresh TTX for 7 days. (b) Cell
survival rates of primary neuronal cultures following the application of
conditioned medium of cells that were treated for 4 days with TTX
(‘wash conditioning’) and left for 3 more days in fresh medium, with or
without the addition of fresh TTX, for 7 days (c) The change in tPA
mRNA expression level in primary neuronal cultures following a week
of incubation in TTX- or wash-conditioned medium (means6SEM;
*P ,0.05).
doi:10.1371/journal.pone.0025919.g002
tPA and Neuronal Cell Death
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The present results support a role for tPA in mediating activity
deprivation-induced neuronal cell death. tPA’s role in neuronal
survival and death paradigms is quite diverse and controversial -
there are many reports supporting its pro-survival effect on neurons
both in-vivo and in-vitro [15–18], but other studies have
demonstrateditstoxiceffectortheprotectiveeffectofitsendogenous
inhibitor PAI-1 when secreted from astrocytes [19–21]. Our study
reinforces the proposed involvement of tPA in neuronal death
cascades, and also provides evidence for neuronal-originated PAI-1
(rather than glial) being beneficial in counteracting tPA toxic effects.
tPA mRNA expression levels were found to be elevated
throughout TTX treatment in a gradual manner, corresponding
to neuronal demise (Fig. 1A&C). This was not different from other
genes tested, such as TNF which is an important mediator of
neuronal apoptosis (Fig. 1B), but unlike these other genes, tPA
remained highly elevated during the recovery period in which cells
were dying independently of TTX presence. Assuming that
neuronal death mechanisms are the same for both the chronic and
the ‘wash’ phases, it is reasonable to assume that tPA has a major
role in the death process in both conditions. The elevation in the
mRNA level was accompanied by a corresponding elevation in the
intracellular and intranuclear tPA protein levels in the treated
neurons (chronically and washed, Fig. 1D) compared to control
cells, suggesting that in our case, tPA may play an intracellular role
in the death cascade. Another reinforcement for the suggestion
that tPA may not mediate the death process in an extracellular
manner is in the observation that secreted factors are playing no
role in this cell death process as demonstrated in Fig. 2, showing
that TTX-conditioned medium (containing TTX) was as potent as
freshly-added TTX in eliciting cell death, and that the conditioned
medium of cells in their recovery period is not toxic at all to naı ¨ve
cells (Fig. 2A&B). Similar to the induction of tPA by chronic TTX
treatment, there was a linear relation between tPA induction and
the severity of the cell death exerted by the different types of
conditioned media (Fig. 2C). If tPA is to play a crucial role in this
death process, then blocking its activity would result in a protective
effect on the dying neurons. To test this possibility we utilized the
endogenous inhibitor of tPA in the cell, PAI-1, which is implicated
by itself as a neuronal protecting agent. PAI-1 over-expression
resulted in an increase in cell survival rates among TTX-treated
neurons relative to cell transfected with a GFP or non transfected
at all (Fig. 3). As before, the transfection experiments reinforce the
assumption that tPA acts intracellularly, since application of the
recombinant PAI-1 protein to the growing medium of the cells was
shown not to be effective at all in elevating cell survival rates,
unlike the case of the expression plasmid (unpublished data).
One of the reasons that neurodegenerative diseases are of a
major concern is the fact that they are terminal and cureless as
they are often diagnosed too late for medical intervention. For this
reason preventive medicine which will engage in the early, pre-
symptomatic stages of the disease should be developed - by
detecting suspicious signs in specific neuronal populations (for
example, elevation in tPA protein which occurs already after 4
days of treatment, Fig. 1C) we could try and treat them locally (for
example by attenuating tPA activity, Fig. 3C) and prevent their
demise and the collateral damage accompanied to it. We therefore
believe that our study places tPA in a promising position as a
future therapeutic target for neuroprotection.
Materials and Methods
Cultures
Wistar rat pups were decapitated on postnatal day 3 (P3) and
their brains removed and placed in a chilled (4uC), oxygenated
Figure 3. Intrinsic blockade of tPA protects neurons from TTX-mediated neuronal cell death. (a) Representative images of control and
TTX-treated neuronal cultures stained for the neuronal marker NeuN (red), and for the tPA inhibitor PAI-1 (green), transfected with either GFP, PAI-1
or non-transfected controls (bar=100 mm). (b) Control and TTX-treated neurons were stained for NeuN and for PAI-1. Cell survival rates of the NeuN-
positive cells and of the PAI-1-positive cells out of the NeuN-positive population were estimated. (c) Cell survival rates of double-labeled cells of the
three groups - Non-transfected, GFP and PAI-1, demonstrating the protection exerted by the over-expression of PAI-1.
doi:10.1371/journal.pone.0025919.g003
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enriched with 0.6% glucose and Gentamicin (20 mg/ml; Sigma,
St. Louis, MO). Bilateral cortical tissue was mechanically
dissociated and plated on 12-mm glass coverslips at 4610
5 cells
per well in a 24-wells plate, or on 35 mm culture dishes at 1.5 to
2610
6 cells. The plating medium consisted of 5% heat-inactivated
horse serum (HS) and 5% fetal calf serum and was prepared in
MEM (minimal essential medium)-Earl salts (Biological Industries,
Beit Haemek, Israel) enriched with 0.6% glucose, Gentamicin, and
2 mM glutamax. Cells were left to grow in the incubator at 37uC,
5% CO2 for 4 days, at which time the medium was changed to
10% HS in enriched MEM, plus a mixture of 59-fluoro-2-
deoxyuridine/uridine (Sigma, 20 mg and 50 mg/ml, respectively).
The medium is changed 4 days later to 10% HS in enriched
MEM. TTX (at 1 mM, Alomone labs, Jerusalem, Israel) was added
to the growth medium at 4 days in culture for up to 14 days of
incubation period.
Transfection
A lipofectamine 2000
TM (Invitrogen, Carlsbad, CA, USA) mix
was prepared at 1 ml/well with 50 mL/well optimem
TM (Invitro-
gen, Carlsbad, CA, USA) and incubated for 5 min at room
temperature. This was mixed with 1.5 mg/well total DNA in
50 ml/well optimem
TM and incubated for 15 min at room
temperature. The mix was then added to the cells and allowed
to rest for 4–6 h until medium replacement. In most cases, at least
several neurons were transfected. Co-transfection efficiency for
several plasmids using this method was nearly 100%.
Immunocytochemistry
Cultures were washed briefly with standard extracellular
solution (129 mM NaCl, 4 mM KCl, 10.5 mM glucose and
10 mM and HEPES, pH=7.4), fixed in 4% paraformaldehyde
with 4% sucrose for 20 min, and washed with phosphate-buffered
saline (PBS). For fluorescence staining cells were blocked for 1 h in
10% GS with 0.1% triton X-100 and incubated overnight at 4uC
with mouse aNeuN (chemicon, Massachusetts, USA; 1:1000),
rabbit atPA (1:400, Santa Cruz, California, USA) or rabbit aPAI-
1 (1:500, Santa Cruz, California, USA) followed by 1 h secondary
antibody labeling (Alexa 488-labeled and Alexa 546-labeled goat
anti-mouse - Molecular Probes, Eugene, OR; 1:200). Cover slips
were washed again, transferred onto glass slides and mounted for
visualization with anti-fading mounting medium. Confocal image
stacks were recorded using a Zeiss LSM 510 laser scanning
microscope, a Zeiss 406and 1006oil immersion objective. About
4 fields are taken per 12 mm coverslip for statistical analysis, at
each case.
Quantitative reverse transcriptase (RT) Real Time-PCR
analysis
Total cellular RNA was isolated using Qiagen RNeasy mini kit
according to manufacture’s instructions. Reverse transcription was
performed with oligo dT primers and the RevertAid RT enzyme
(Fementas) at 42uC for 60 min. The RT product from 500 ng of
total RNA was applied to each 20-mL PCR reaction mixture
containing 16 Absolute Blue Cyber Green PCR Mix (Thermo
Scientific) and 250 nm of gene-specific forward and reverse
primers. Each experimental set consisted of duplicate samples,
non-template controls and serial dilutions of standard templates.
PCR was performed in Rotor-Gene 6000 apparatus of Corbett
with the following thermal cycle conditions: 15 min enzyme
activation at 95uC and subsequent 40 three-step cycles of 95uC for
15 sec, 55uC for 30 sec and 72uC for 30 sec. As a reference,
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and micro-
tubule associated protein 2 (MAP2) cDNA levels were used. The
rat specific primers used were the following:
GAPDH - fw 59 TCAACGGCACAGTCAAGGC 39,r v5 9
CGCTCCTGGAAGATGGTGAT 39;
NSE - fw 59 GCCGGCCTTTAATGTGATCAA 39,r v5 9
CATGGCCAACTTGTTCCCAG 39;
TNF - fw 59 GAGGTCAACCTGCCCAAGTACT 39,r v5 9
CTGGGTAGAGAACGGATGAACAC 39;
tPA - fw 59 TGCCCTAAGGGACCAACTGA 39,r v5 9
TGGGTGCCACGGTAAGTCA 39;
Emission data were analyzed by the Rotor Gene program and
cycle threshold (CT) number was calculated automatically by it.
We also verified that there was no detectable amplification in non-
template controls. CT numbers showed a significant linear reverse
correlation with logarithmic concentrations of standard templates.
The original copy numbers of the first strand cDNA in RT
samples were calculated from the CT numbers by fitting to the
obtained standard correlation.
Statistics
Every experiment was repeated at least 3 times, with several
wells/35 mm dishes used for each treatment. The morphological
data were summarized and analyzed automatically using Image-
Pro Plus software. The stained neurons were counted in several
fields of view in each glass. The statistical analysis of the data was
done using t-tests or analysis of variance (ANOVA), after its
normal distribution was verified using Shapiro-Wilk normality test.
Significance was set at P,0.05.
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